Predictive Biology Awarded National Institutes of Health (NIH) Grant to Develop Stem Cells for Reproductive Toxicology

CARLSBAD, CA - SEPTEMBER 14, 2009 - Predictive Biology today has received a Small Business Innovation Research (SBIR) Phase II grant from the National Institute of Environmental Health Sciences (NIEHS) to develop embryonic stem cells for understanding the role of genetics in reproductive toxicology. The grant provides approximately $940,000 in research and development funds for a Phase II study.

Ted Choi, President and Chief Scientific Officer for Predictive Biology is the Principal Investigator and will lead the research and development effort. "We are very excited to apply our novel stem cell genetics approach to reproductive toxicology" said Choi. "We believe we can significantly improve the relevance and predictive power of in vitro toxicology."

Predictive Biology Awarded National Institutes of Health (NIH) Grant to Discover Factors Determining Cardiomyocyte Differentiation

CARLSBAD, CA - MAY 23, 2008 - Predictive Biology has received a Small Business Innovation Research (SBIR) Phase I grant from the National Heart, Lung, and Blood Institute (NHLBI) to develop novel genetics technologies to identify factors that influence production of heart cells from embryonic stem cells. The grant provides approximately $447,000 in research and development funds for a Phase I study.

"We are thrilled to have the support of the NHLBI in developing our unique stem cell genetics platform for regenerative medicine" said Ted Choi, President and Chief Scientific Officer. "In this program, we will discover novel genes and cell treatments to obtain therapeutically useful cardiomyocytes to treat heart disease and other cardiovascular disorders."